0000075252-19-000066.txt : 20190408 0000075252-19-000066.hdr.sgml : 20190408 20190408091042 ACCESSION NUMBER: 0000075252-19-000066 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190408 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190408 DATE AS OF CHANGE: 20190408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OWENS & MINOR INC/VA/ CENTRAL INDEX KEY: 0000075252 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 541701843 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09810 FILM NUMBER: 19736541 BUSINESS ADDRESS: STREET 1: 9120 LOCKWOOD BLVD CITY: MECHANICSVILLE STATE: VA ZIP: 23116 BUSINESS PHONE: 8047237000 MAIL ADDRESS: STREET 1: 9120 LOCKWOOD BLVD CITY: MECHANICSVILLE STATE: VA ZIP: 23116 FORMER COMPANY: FORMER CONFORMED NAME: O&M HOLDING INC DATE OF NAME CHANGE: 19940504 FORMER COMPANY: FORMER CONFORMED NAME: OWENS & MINOR INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: OWENS MINOR & BODEKER INC DATE OF NAME CHANGE: 19811124 8-K 1 smh8k.htm 8-K Document


 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
 
 
 FORM 8-K
 
 
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 8, 2019
 
 
 
Owens & Minor, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
 
 
Virginia
 
1-9810
 
54-1701843
(State or other jurisdiction
of incorporation
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
 
 
9120 Lockwood Blvd., Mechanicsville, Virginia
 
23116
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code (804) 723-7000
Not applicable
(former name or former address, if changed since last report.)
 
 
 

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company    o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.             o
 
 
 
 
 




Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective April 5, 2019, Stuart Morris-Hipkins, President - Global Solutions of Owens & Minor, Inc. (the “Company”), left the Company to pursue other opportunities.

Item 7.01 Regulation FD Disclosure

The information set forth in Item 5.02 above is incorporated herein by reference. The Company’s Chief Executive Officer & President, Edward A. Pesicka, will assume Mr. Morris-Hipkins’ responsibilities with respect to the Company’s U.S. Distribution business. Additionally, Jeffrey Jochims, who joined the Company as Executive Vice President, Strategy & Solutions effective April 8, 2019 and reports directly to Mr. Pesicka, will assume Mr. Morris-Hipkins’ responsibilities with respect to the Company’s Provider Solutions, Manufacturer Solutions, Movianto and Fusion 5 businesses.

On April 8, 2019, the Company issued a press release announcing the appointment of Mr. Jochims as Executive Vice President, Strategy & Solutions. A copy of this press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference into this Item 7.01.

The information set forth in this Item 7.01 including the information set forth in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.


Item 9.01 Financial Statements and Exhibits
(c) Exhibits.





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
 
 
OWENS & MINOR, INC.
 
 
 
 
April 8, 2019
 
 
 
By:
 
/s/ Nicholas J. Pace
 
 
 
 
 
 
Name:
 
Nicholas J. Pace
 
 
 
 
 
 
Title:
 
Executive Vice President, General Counsel and Corporate Secretary



 EX-99.1 2 pressrelease_jeffreyjochim.htm EXHIBIT 99.1 Exhibit


Exhibit 99.1

Owens & Minor Names Jeffrey Jochims Executive Vice President, Strategy & Solutions
Senior Executive Brings Proven Distribution, Manufacturing and Services Expertise
 


RICHMOND, VA – April 8, 2019 – Today Owens & Minor Inc. (NYSE: OMI) announced the appointment of Jeffrey Jochims as Executive Vice President, Strategy & Solutions, effective April 8, 2019.  Jochims, formerly a long-tenured executive at Thermo Fisher Scientific, joins the company with more than 25 years of business strategy and operations experience focused on distribution, manufacturing and services in the healthcare, biopharmaceutical and life sciences research industries.
 
“We are delighted to bring someone with Jeff’s experience to our team,” said Ed Pesicka, President & Chief Executive Officer. “He is an accomplished, results-oriented and high-integrity leader, with an excellent track record of developing winning strategies and teams and increasing value across a wide range of global businesses. He is a seasoned leader with proven skills in integrating and transforming businesses. We are very pleased to have him join the Owens & Minor team."
 
“I am thrilled to join Owens & Minor at such an important time in the healthcare industry,” said Jochims. “Every day our customers need to deliver better, more cost-effective outcomes. To do that, they need Owens & Minor to be right beside them, delivering on our commitments and adding value through world-class products and innovative solutions and services. We will be laser focused on fulfilling that responsibility. I am honored to help steer Owens & Minor’s strategy and to lead the Solutions team in this next chapter of our company.”
 
In his new role, Jochims will serve as chief strategy officer and lead the Solutions portfolio including Provider Solutions, Manufacturer Services, Movianto and the Fusion5 relationship. He will report to Ed Pesicka and become a member of the executive leadership team.

Additional Updates
In additional news, Stuart Morris-Hipkins has departed from the company to pursue other opportunities. O&M US Distribution, including US Sales Operations, US Distribution Operations, and Strategic Supplier Management, will now report to President and CEO Ed Pesicka. 

Jeffrey Jochims Biography
Jochims, 51, has held several key leadership roles throughout his 25-year plus career. A longtime member of the senior leadership team for Thermo Fisher Scientific, his roles and responsibilities progressed, culminating with his appointment as President of the Fisher Safety & Fisher Scientific divisions.  In his role as President, Jochims’ customer-centric approach and ability to deliver results led to above-market growth and share gains.

More recently, Jochims has served as an executive consultant, Board member and advisor to several companies in the healthcare and life sciences industries focused on strategy development and execution, operational excellence and commercial sales and marketing.
 
Jochims holds a Juris Doctorate degree from the University of Pittsburgh School of Law and a B.A. from the University of Illinois.
 
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and




manufacturers across the continuum of care. With 17,000 dedicated teammates serving healthcare industry Customers in 90 countries, Owens & Minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. A FORTUNE 500 company, Owens & Minor was founded in 1882 in Richmond, Virginia, where it remains headquartered today. The company now has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. For more information about Owens & Minor, visit the web, follow on Twitter, and connect on LinkedIn.

Contact
Jenny Graves, 804-723-7754
VP Global Corporate Communications
jenny.graves@owens-minor.com